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ABSTRACT 
Author: Sethunath, Deepak. MS 
Institution: Purdue University 
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Title:  Detection of Histological Features in Liver Biopsy Images to Help Identify Non-Alcoholic 
Fatty Liver Disease. 
Major Professor: Mihran Tuceryan 
 
This thesis explores a minimally invasive approach of diagnosing Non-Alcoholic Fatty Liver 
Disease (NAFLD) on mice and humans which can be useful for pathologists while performing 
their diagnosis. NAFLD is a spectrum of diseases going from least severe to most severe – steatosis, 
steatohepatitis, fibrosis and finally cirrhosis. This disease primarily results from fat deposition in 
the liver which is unrelated to alcohol or viral causes. In general, it affects individuals having a 
combination of at least three of the five metabolic syndromes namely, obesity, hypertension, 
diabetes, hypertriglyceridemia, and hyperlipidemia. Given how common these metabolic 
syndromes have become, the rate of NAFLD has increased dramatically over the years affecting 
about three-quarters of all obese individuals including many children, making it one of the most 
common diseases in United States. Our study focuses on building various computational models 
which help identify different histological features in a liver biopsy image, thereby analyzing if a 
person is affected by NAFLD or not. Here, we develop and validate the performance of automated 
classifiers built using image processing and machine learning methods for detection of macro- and 
microsteatosis, lobular and portal inflammation and also categorize different types fibrosis in 
murine and human fatty liver disease and study the correlation of automated quantification of 
macrosteatosis, lobular and portal inflammation, and fibrosis (amount of collagen) with expert 
pathologist’s semi-quantitative grades. Our research for macrosteatosis and microsteatosis 
prediction shows the model’s precision and sensitivity as 94.2%, 95% for macrosteatosis and 
79.2%, 77% for microsteatosis. Our models detect lobular and portal inflammation(s) with a 
precision, sensitivity of 79.6%, 77.1% for lobular inflammation and 86%, 90.4% for portal 
inflammation. We also present the first study on identification of the six different types of fibrosis 
having a precision of 85.6% for normal fibrosis and >70% for portal fibrosis, periportal fibrosis, 
pericellular fibrosis, bridging fibrosis and cirrhosis. We have also quantified the amount of 
collagen in a liver biopsy and compared it to the pathologist semi-quantitative fibrosis grade. 
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1. INTRODUCTION 
  This thesis involves building classifiers to detect different histological features in a liver 
biopsy image which in turn will help in the identification of non-alcoholic fatty liver disease 
(NAFLD). This is a novel approach of detecting NAFLD, predominantly because we not only 
identify steatosis or inflammation in liver but also classify different types of fibrosis, and quantify 
the amount of fibrosis. 
 Motivation 
  Medical technology is imperative for the betterment of people’s health and well-being. It 
also contributes billions of dollars to the economy. Innovative technology is a perquisite to 
healthcare. 
  NAFLD is subdivided into nonalcoholic fatty liver (NAFL) and nonalcoholic 
steatohepatitis (NASH) although these are considered to be part of a spectrum. In NAFL, hepatic 
steatosis is present without evidence of hepatocyte ballooning degeneration or significant 
inflammation, whereas in NASH, hepatic steatosis is associated with hepatocyte ballooning 
degeneration and hepatic inflammation that may be histologically indistinguishable from alcoholic 
steatohepatitis (1). 
  According to Younossi et al. NAFLD is one of the most important causes of liver disease 
worldwide in adults and children due to the pandemic spread of obesity. “Global prevalence of 
NAFLD is estimated at 24%; the highest rates are reported from South America and the Middle 
East, followed by Asia, the USA and Europe. The large volume of patients sets NAFLD apart from 
other liver disease, meaning the major focus of clinical care is discerning those at highest risk of 
progressive liver disease. Being overweight in childhood and adolescence is associated with 
increased risk of NAFLD later in life; consequently, the threshold of liver-related morbidity and/or 
mortality is reached at a younger age. Patients with NAFLD have a high risk of liver-related 
morbidity and mortality along with metabolic comorbidities and might place a growing strain on 
health-care systems” (2). 
Liver biopsy is the gold standard for the diagnosis of NAFLD and has been accepted 
worldwide. The nonalcoholic fatty liver activity score (NAS) is a system of histologic evaluation 
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that includes the full spectrum of nonalcoholic fatty liver disease and can assess changes following 
therapy in both adult and pediatric patients. The NAS is the unweighted sum of scores for Steatosis, 
Lobular inflammation and Ballooning. The NAS ranges from 0 to 8. Fibrosis is not included in the 
NAS (1).  
  In recent years, different pathologic criteria have been used to carry out epidemiological 
studies or to assess the efficacy of different medications in clinical trials of patients with NASH 
Despite their increasing use, the interprotocol agreements of these pathological criteria have not 
been assessed (3). This leads to considerable differences in the scoring of histological feature 
grades by various pathologists. These grades can differ, either when comparing different 
pathologists grading the same liver sample or a single pathologist grading the same liver sample 
at different times. There are several studies which discuss the consistencies  and the inconsistencies 
in pathologist evaluation (4). 
 Problem Statement 
  The purpose of this study is to build an automated tool which can help in the identification 
of Non-alcoholic Fatty Liver Disease (NAFLD) by detection and quantification of different 
histological features like steatosis, inflammation and fibrosis. Steatosis detection involves the 
determination of the two different types – microsteatosis and macrosteatosis. Inflammation 
detection involves the determination of the two different types of inflammation, i.e., portal and 
lobular inflammation. Apart from this, categorization of different types of fibrosis is required to 
determine the level of NAFLD. The identification of these different histological features enhances 
the diagnosis of liver disease and gives accurate measures of NAFLD. This research is an extension 
of the previous work done by Morusu et al. (5, 6) at Purdue University and Vanderbeck et al. (7-
9) at the University of Wisconsin where the use of these automated methods to detect and quantify 
histological features in liver biopsy images to aid in the diagnosis of NAFLD have been assessed. 
 Contributions of this thesis 
  This study deals with the detection of different histological features which aid in the 
diagnosis of NAFLD. The approach involves taking expert pathologists annotations as training 
labels (of different histopathological and anatomical structures) in liver biopsy images and perform 
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image processing on the set of liver biopsy slides, thereby extracting different set of features which 
uniquely identify an area within them. These features are computed on the expert pathologist 
annotated areas to build different machine learning models which can then be used to correctly 
classify the type of histological feature present in liver biopsies. This research is an extension of 
previous work done by Morusu et al. (5, 6) and therefore, my contributions are listed below. 
 
 Enhancing the Web Annotation Tool 
The web annotation tool used by pathologists for extraction of annotations in a 
liver biopsy has been updated. The pathologist can now annotate different types of fibrosis, 
other than the existing set of histological and anatomical regions present in a liver biopsy. 
The annotation tool now has a rich and responsive user interface that can handle the usage 
of it in different resolutions.  
 
 Identification of steatosis in liver biopsies 
The detection and quantification of steatosis in liver biopsies play an important role 
in the detection of NAFLD as it is the instigating process of the same. Studies have shown 
that 5 to 15% of patients with NAFLD present with established cirrhosis on liver biopsy 
and that 4 to 5% of individuals with isolated steatosis eventually developed cirrhosis (10). 
Steatosis detection involves the detection of both macrosteatosis and microsteatosis. This 
study enhances the performance of previous classifiers built by Vanderbeck et al. (7-9) and 
Morusu et al. (5, 6) to detect macrosteatosis and also performs an analysis to correlate the 
results with semi-quantitative grades given by expert pathologists. Apart from this, our 
study proposes a new method to detect the presence of microsteatosis in liver biopsies. The 
models developed as part of this study detect steatosis in liver biopsies with precision, 
sensitivity and ROC area of 94%, 95% and 99.1% for macrosteatosis and 79.2%, 77%, 
78.1% for microsteatosis respectively. The correlation results for macrosteatosis quantified 
by our model and the expert semi-quantitative grade for steatosis has a coefficient of 
determination (𝑅2) value of 0.905.  
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 Identification of Inflammation in liver biopsies 
The detection and quantification of inflammation in human liver biopsies is 
something that has also been addressed as part of this research. There are two types of 
inflammation detection that has been done, namely, lobular inflammation and portal 
inflammation. While both of them are equally important in the detection of NAFLD in 
children, the former plays a very important role in detecting NAFLD in adults as well. In 
this work, improvements have been made to the supervised machine learning models built 
by Morusu et al. as part of their study to detect inflammation (11). The models developed 
as part of this study detect inflammation in human liver biopsies with precision, sensitivity 
and ROC area of 79.6%, 77.1% and 93.2% for lobular inflammation and 86%, 90.4%,   
92.6% for portal inflammation. The correlation results for both types of inflammation 
detected and quantified by our model and the expert semi-quantitative grade for both 
lobular and portal inflammation have a spearman coefficient of determination of 0.71 and 
0.85 respectively. 
     
 Identification of Fibrosis in liver biopsies 
The detection of fibrosis and its types in human liver biopsies is the next problem 
addressed in this research. Fibrosis is essential in diagnosing NAFLD and it is classified 
into various types based on the amount and location of collagen present. This study 
computes the amount of collagen content and performs correlation with the pathologists’ 
semi-quantitative grades given to the human liver slides. It also presents the first study to 
detect different types of fibrosis namely, normal fibrosis, pericellular fibrosis, portal 
fibrosis, periportal fibrosis, bridging fibrosis and cirrhosis. 
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2. BACKGROUND 
 Liver Anatomy 
  Liver is the largest organ and gland in the human body accounting to about 1/50th body 
weight of a normal adult. The liver occupies the upper right quadrant of the abdomen to the right 
of the stomach and immediately below the diaphragm and is divided by the falciform ligament into 
a larger right lobe and a smaller left lobe. The liver has association with the gastrointestinal tract, 
with stomach related to the left hepatic lobe by way of gastrohepatic ligament which has neural 
and vascular structures including the hepatic division of the vagus nerve. The transverse colon is 
sometimes near or in direct contact with right lobe and additionally, duodenum and portal 
structures are associated with the hepatoduodenal ligament and porta hepatis thus making liver a 
major highway for transporting oxygenated and deoxygenated blood from these organs to the heart 
(12). At the microscopic level, the liver cells (known as hepatocytes) are arranged into lobules. 
These form the structural units of the liver. The anatomical lobules are hexagonal-shaped and are 
drained by central veins (Figure 2-1). The periphery of each of the hexagons consists of three 
structures broadly known as the portal triad which comprises of the following: 
 Arteriole – a branch of the hepatic artery entering the liver. 
 Venule – a branch of the hepatic portal vein entering the liver. 
 Bile duct – branch of the bile duct leaving the liver (13). 
 
 
Figure 2-1 : Portal Triad – regions of connective tissue which include branches of bile duct, portal 
vein and hepatic artery (13). 
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 The liver aids the digestion of food thereby producing vital nutrients and excretion of waste 
material from the body. The liver plays several vital roles such as metabolizing the breakdown 
products of digestion and detoxifying substances that are harmful to the body. The liver also 
provides essential energy producing substances. The liver controls the production and excretion of 
cholesterol and metabolizes alcohol into mild toxin. It also performs many important functions 
including storing iron, maintain hormonal balance, producing immune factors, regulating blood 
clotting, and producing bile (14). 
 Liver Biopsy 
  Liver biopsy is a minimally invasive method of taking a small section of tissue from the 
liver and looking under the microscope for signs of damage or disease. It is the gold standard for 
diagnosing NASH (non-alcoholic steatohepatitis) and assessing stages of fibrosis patients with 
NAFLD (non-alcoholic fatty acid liver disease). NAFLD is a spectrum of diseases varying from 
least severe steatosis, to more severe and progressive steatohepatitis to the most severe phenotype 
of disease; NASH with advanced fibrosis and cirrhosis. It is mainly caused by deposition of fat in 
the liver and it affects individuals with metabolic disorders like obesity, hypertension, diabetes, 
hypertriglyceridemia and hyperlipidemia. 
Liver biopsy procedure is conducted to determine the cause of abnormal liver function, 
swelling or enlargement of the liver and jaundice. These signs and symptoms are due to a variety 
of conditions including cirrhosis, hepatitis or cancer (15). 
  The most commonly used liver biopsy method is percutaneous biopsy where ultrasound 
imaging is used to guide a needle into the liver. A numbing medication is injected to the area where 
the needle is inserted by making small incision near the bottom of the rib cage on the right side are 
done to obtain the liver sample. The tissue sample is fixed in zinc tris at 4°C for 24 hours followed 
by chemical processing steps after which the sample is divided into sections of 5 micrometer 
thickness for further analysis under a microscope by different staining methods. The current study 
used two stains: 
1. Hematoxylin and Eosin Stain (H&E) stain helps in making the biopsy section turn pink 
and blue shades which aids in identifying different areas of the cells. Cell nuclei appear in 
shade of blue and the cytoplasm in pink. 
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2. Trichrome Stain (TC) stain turns the biopsy section into three colors: red, blue and pink. 
Cell nuclei appear in blackish to brown color while fibrosis, the connective tissue which is 
scarred due to injury appears in blue and cytoplasm appears red in color. 
 
 
Figure 2-2 : An example of a liver biopsy. A. H&E Stain image B. TC Stain image 
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 Histological Features of Non Alcoholic Fatty Liver Disease 
Excessive fat accumulation in the liver of a patient without a history of alcohol abuse is a 
condition known as Non-Alcoholic Fatty acid Liver Disease (NAFLD). It is associated with 
hepatic and systemic insulin resistance and is considered the hepatic manifestation of metabolic 
syndrome. Occurrence of NAFLD among the world population is increasing steadily in 
concurrence with increased prevalence of obesity. Approximately 30% of adult populations of 
developed countries suffer from NAFLD which has also become prevalent in children with obesity. 
NAFLD is categorized into simple steatosis, in which only hepatocellular steatosis occurs and 
nonalcoholic steatohepatitis (NASH), in which both necro inflammatory reactions and 
hepatocellular steatosis occur. NASH accounts for about one third of NAFLD cases and is a 
progressive disease that could advance to liver cirrhosis and liver carcinoma. Additionally, 
NAFLD is associated with insulin resistance, diabetes, and hyperlipidemia (16). 
There are three scoring systems, namely, the Brunt system, the NASH CRN system and the 
SAF system. The Brunt system is a method for grading the severity of NASH and is based on 
criteria of steatohepatitis. The grading of steatohepatitis into mild, moderate and severe was based 
on an overall impression of the severity of steatosis, inflammation and ballooning, but most of the 
weight was given to ballooning. The NASH CRN system is a method developed to detect NAFLD 
histological changes using clinical trials and describe natural history from pediatric and adult 
pattern of NAFLD. NAS (NAFLD Activity Score) is a summary of overall severity of injury and 
is defined as the unweighted sum of the steatosis, lobular inflammation and ballooning scores that 
varies from (0 to 8) (17). 
Histopathological features of NAFLD/NASH in adults are steatosis, lobular and portal 
inflammation, hepatocellular ballooning, fibrosis, glycogenated nuclei, apoptotic hepatocytes, 
MDBs, iron deposition and megamitochondria. 
 
 Steatosis: Hepatocellular steatosis is an indication of NAFLD of the presence of steatosis 
in more than 5% of hepatocytes is required for diagnosis of NAFLD. It is classified into 
two types: macro vesicular and micro vesicular steatosis. Macro vesicular steatosis is 
characterized by the presence of a single large fat droplet or multiple smaller fat droplets 
that occupy the cytoplasm of hepatocytes. Micro vesicular is characterized by presence of 
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tiny fat droplets with the nuclei centrally located in the cell. Macro vesicular is the most 
prevalent form of steatosis with micro vesicular steatosis accounting to approximately 
10% of liver biopsies from patients with NAFLD. 
 
 Lobular inflammation: Acinar (lobular) inflammation in NAFLD is a mild response from 
mixed, acute and chronic inflammatory-cell infiltrate composed of lymphocytes, 
monocytes, macrophages and neutrophils with sinusoids and eosinophils occasionally 
present. In NASH, the inflammatory cells are usually seen near the site of injured 
hepatocytes. Lobular inflammation is evaluated by measuring the number of necro 
inflammatory foci per 20x optical field, and by definition, it measures the cluster of 
inflammatory nuclei that appear spatially together. 
 
 Portal Inflammation: In adult NAFLD, portal inflammation is usually chronic and mild. 
When lobular inflammation is disproportionate to portal inflammation, it is an indication 
of chronic viral hepatitis C. In a different scenario, suspicion of alcoholic or cholestatic 
liver disease is increased when neutrophils infiltrate into the portal and periportal regions. 
Also, increased portal inflammation is a marker of advanced disease in untreated NAFLD 
patients (18). 
 
 Hepatocyte Ballooning: It is characterized by the increase in hepatocyte size of 2 to 3 
times its normal healthy size and presence of Mallory’s hyaline in cytoplasm indicating 
damaged intermediate filaments within hepatocytes due to disintegration of nuclei in 
ballooned cells (16). 
 
 Fibrosis: In NASH, perisinusoidal and pericellular fibrosis is a characteristic of fibrosis 
which usually begins in zone 3 which is evaluated by reticulin staining. In NAFLD it is 
usually observed with an active inflammatory reaction. By general definition, it is the 
development of excessive fibrous tissue by the liver when hepatocytes are damaged 
eventually leading to cirrhosis. 
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 Previous Work 
There have been various research studies to detect NAFLD. Some of them use invasive 
methods while others use non-invasive techniques. There have been multiple studies to detect 
macrosteatosis and fibrosis, some of them even trying to quantify them based on different scoring 
patterns. Apart from Vanderbeck et al. (7-9) and Morusu et al.’s (5, 6) continuous study to 
automatically analyze macrosteatosis and lobular and portal inflammation, there has been no other 
study that has had a big impact. The automatic detection of different types of fibrosis detection 
and of microsteatosis is a new contribution of this thesis.   
2.4.1 Steatosis 
  This section gives a brief overview of the literature associated to the detection of steatosis 
in liver biopsies. In the previous studies done by Vanderbeck et al. (7-9) and Morusu et al. (5, 6) 
detection of macrosteatosis has been done to some extent. In this research, our work optimizes and 
improves their approaches in macrosteatosis detection. In addition, it detects microsteatosis. 
Steatosis is a common liver disease associated with social and genetic factors which can turn into 
cirrhosis. Early detection and quantification is necessary as further delay would evolve it into 
cirrhosis.  
  Ribeiro et al. describes a new non-invasive computer aided diagnosis (CAD) system for 
steatosis classification and analysis where Bayes factor, obtained from objective intensity and 
textural features extracted from Ultrasound (US) images of liver, is computed on a local and global 
basis (19). Each of the US images were stored in the Digital Imaging and Communications in 
Medicine (DICOM) format and a region of interest (ROI) of approximately 100 x 100 were 
extracted. The main features were extracted using the wavelet transform and autoregressive (AR) 
models. A sum of 36 features were extracted from ROI and four types of classifiers (KNN, Bayes 
and SVM (polynomial and radial-basis kernel)) were applied to the images. The procedure has 
shown an overall accuracy of 93.54% with sensitivity of 95.83% and 85.71% for normal and 
steatosis class for 75 patients. Global and local assessment of liver tissue based on the results of 
Bayes factor provides useful information to the physicians about the confidence of class. Further 
studies are needed to validate the results for more number of patients. 
  In another research paper, Homeyer et al. describe a new method in identification of fat 
droplets in histological images derived from liver biopsy (20). It follows a 2-step process, one that 
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classifies individual pixels as either background or tissue and the second step classifies blobs of 
connected background pixels into fat droplets or empty spaces based on their shape. Typically, 
background images should be brighter and less saturated than tissue pixels therefore each pixel is 
classified by thresholds to their brightness and saturation values. In the second step, the blob 
classification step typically is done by performing a connected component labeling operation 
which identifies locally connected background pixel as individual blobs followed by a 
classification operation that classifies all blobs into fat droplets or empty spaces. Here the classifier 
used for the second step is Random Forest Classifier with adjacency statistics, size and eccentricity 
being the features. Correlation to pathologist’s scoring was not used to assess accuracy but 
repeated random sub-sampling validation of fat droplets was used that showed 90% sensitivity and 
specificity. 
 
2.4.2 Inflammation 
  This section discusses the existing methods for detection of inflammation. In the previous 
studies done by Vanderbeck et al. (7-9) and Morusu et al. (5, 6) detection of inflammation has 
been done to some extent and this research optimizes and improves their approaches. 
  In a review paper, Robinson et al. discusses about liver immunology and its role in 
inflammation and homeostasis and highlights few key concepts like the myeloid and lymphoid 
resident immune cell populations are in large proportions in liver (21). According to this paper, 
inflammatory mechanisms are responsible for maintaining local organ and systemic hemostasis in 
a healthy liver. But excessive or dysregulated inflammatory activity leads to the pathology 
associated with autoimmune and infectious hepatic disease. The hepatic environment is highly 
influenced by high fat and carbohydrate diet in the hepatic blood supply. Carbohydrates are usually 
stored as glycogen whereas, dietary fat transported from the gut are chylomicrons that are 
processed into lipoproteins. The lipoproteins and carbs contain cholesterol, triglycerides and 
succinate that trigger inflammatory response by promoting TLR signaling and inflammasome 
activation. This metabolic regulation of inflammation is important in non-alcoholic fatty liver 
disease. The detection of inflammation is possible by liver biopsy which is a minimally invasive 
diagnostic test currently considered to be the “gold standard”. 
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  Generally, inflammation is an immediate response to an injury near the site. A lobular 
inflammation in NAFLD is a mild response from mixed acute and chronic inflammatory-cell 
infiltrate composed of lymphocytes, monocytes, macrophages and neutrophils. A portal 
inflammation in NAFLD is a chronic to mild response and it is an accumulation of neutrophils 
infiltrate in portal and periportal regions. Previously, the detection of different kinds of 
inflammation, which play a role in NAFLD, used semi-quantitative methods that are subjective 
and they lacked experienced pathologists to validate (18). 
 
2.4.3 Fibrosis 
This section discusses the evolution of methods for evaluating fibrosis. There have been 
various studies involving the detection of fibrosis in liver biopsies, however, the studies either lack 
the validation from the expert pathologists or do not detect all the different types of fibrosis. Let 
us discuss a few of the methods already proposed in the literature. 
  Masseroli et al. discuss FibroQuant as a robust, reproducible and rapid method for precisely 
quantifying the degree of hepatic fibrosis as opposed to semi-quantitative methods (22). These 
semi-quantitative methods do not describe the localization and the pattern of hepatic lesions. Their 
scoring methodology is inefficient for precise quantifications and is not sufficiently sensitive to 
detect small changes in fibrosis. Thus, computerized digital image analysis for precise 
quantification of liver fibrosis was proposed which does better than semi-quantitative methods. It 
also correlates well with calorimetric method, which quantifies total collagen in a tissue section. 
The method enables separate quantification on a single liver histologic image of perisinusoidal, 
perivenular, and portal-periportal and septal fibrosis, and portal-periportal and septal morphology. 
This automatic segmentation of fibrosis areas produced different intra- and interoperate results, 
which is an important step in the prognosis of hepatic diseases. However, the disadvantage of this 
method is the lack of an experienced pathologist to validate the results which therefore, undermines 
the efficiency and validity of the method. 
As semi-quantitative methods proved to be inefficient because evaluation of fibrosis is 
subjectively dependent on the visual interpretation by the observer who is not an experienced 
pathologist, a recent study by Dahab et al. uses quantification of fibrosis by computer software  
using image processing techniques (23). This method answers a few of the pitfalls of semi-
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quantitative methods by looking at the stained biopsies. The software handles images acquired 
from stained connective tissues of liver and converts it into a binary image, applying shading 
correction and automatic thresholding, thus extracting the fibrosis area from digitized black and 
white image. Further, a polygon around the fibrosis area and lumen areas is drawn manually and 
a set of Boolean operations are performed allowing the calculation of the total area of the region 
of interest. Such a method results in many errors because processes like thresholding and 
converting color images into grayscale discard image information that could be useful in assessing 
the contours of the image more accurately. Extracting perisinusoidal or multifocal fibrosis by this 
method is impossible adding calculative errors to the method. Finally, considering only sections 
of the image would add bias because comparison between tissue patterns must be performed in a 
global fashion.  This method also lacks an experienced pathologist to validate, and does not address 
other regions of fibrosis and does not classify each type of fibrosis. 
The next method by Dioguardi et al. claims to be highly objective so far compared to several 
qualitative, semi-quantitative and digitized image processing methods by using completely 
automated methods (24). The principle of this method is the theory of measurement of all clustered 
and non-clustered inflammatory cells. By using specific formulas mentioned in the paper, the 
authors offer a geometrically described morphometry of the histological picture for a liver biopsy. 
The paper only discusses if the fibrosis is normal or not normal based on calculating different 
hematological indices which are either dispersed or clustered but are do not individually classify 
each type of fibrosis based on collagen content and several other morphological characteristics 
(24). 
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3. METHODOLOGY 
This thesis is an extension and improvement of Vanderbeck et al. (7-9) and Morusu et al.’s 
study (5, 6) to build models using supervised machine learning techniques for detection of different 
histological features which in turn aid in the diagnosis of NAFLD. This study addresses the 
identification of various histological features like macrosteatosis and microsteatosis, portal 
inflammation and lobular inflammation, and also detecting different types of fibrosis including, 
normal fibrosis, pericellular fibrosis, portal fibrosis, periportal fibrosis, bridging fibrosis, and 
nodules. 
For this study, liver biopsies are taken from human or mice liver, scanned and digitized to 
which low-level image processing techniques followed by machine learning techniques are applied. 
These liver biopsies are assigned semi-quantitative grades by expert pathologists. The expert 
pathologists are provided with a web-based annotation tool, which enables them to annotate 
different histological features in a liver biopsy providing class labels which are then used for 
building supervised machine learning models. Image processing is performed on the liver biopsy 
slide images to extract image features. Firstly, background/foreground extraction is used to 
identify the tissue area in the image. 
One sub-component of the system is developed to identify and quantify steatosis in the liver 
biopsy. Once the tissue area is identified, using different segmentation methods, white regions in 
the liver biopsy are detected which are then used for steatosis identification. Based on the 
annotations provided by the pathologists, a supervised machine learning model is built by 
extracting different types of features like morphological features, texture based features and scale-
space representation features to identify different kind of white regions in the slide. The white 
region extraction technique is diagrammatically explained in Figure 3-9. Once the model is built, 
unseen samples of liver biopsies are input to the model which then detects and quantifies the 
amount of microsteatosis and macrosteatosis. The percentage of steatosis calculated is thus 
correlated with the semi-quantitative grades given by the experts. 
A second sub-component is developed to detect inflammation in the biopsy images. The first 
step in inflammation detection is the detection of the dark regions in an image. This involves 
similar methods defined to detect the tissue area and the nuclei in steatosis extraction, and then 
extraction of different kinds of features to detect dark regions in the liver biopsy. Once the dark 
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regions in a liver slide are identified, the percentage of lobular and portal inflammation in a tissue 
is quantified and is thus correlated with the semi-quantitative grades provided by the expert 
pathologists. 
 
Figure 3-1 : The flow diagram presenting the overall approach. 
 
The third sub-component is the detection and classification of various types of fibrosis in the 
liver biopsy. The approach to detect different kinds of fibrosis is explained in the Figure 3-14. This 
involves the extraction of blue regions in a TC stained liver biopsy using image segmentation 
techniques. In order to detect the various types of fibrosis, supervised machine learning models 
are built to detect each type separately, involving the extraction of blue regions in an image and 
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performing various feature extraction techniques on the regions annotated by experts, which help 
uniquely identify the type of fibrosis content.   
 Types of Biopsy Data Used 
  In this study, there are two sources of liver biopsy data used, namely, mice liver and human 
liver biopsies.  The use of mice liver biopsies can be useful under certain situations and can be 
more easily obtained.  Moreover, the protein coding regions of mice and human genomes are 85% 
identical on an average (some genes are 99% identical, while others are 60% identical) (25). 
 
a) Mice Liver Biopsies 
  This experimental study chooses mice liver biopsies from the available set of 40 
liver biopsies. These set of biopsies are affected with different levels of NAFLD and its 
histological features, ranging from level 0 to level 3 (level 0 through level 4 in case of 
fibrosis). From the existing dataset, there are 9 liver biopsies which are not infected with 
NAFLD. Figure 3-3 shows a bar graph representation of the current set of liver biopsies 
and amount of affected samples with respect to each histological feature. As there is more 
variety for steatosis affected samples in comparison to the others, we use a subset of those 
affected liver biopsies for this study. The dataset used for this study consisted of digital 
images of 27 H&E stained slides of murine liver biopsies [9 with normal liver histology 
(no macrosteatosis: grade 0), 10 mild (macrosteatosis grade 1), 4 moderate (macrosteatosis 
grade 2), and 4 severe fatty liver (macrosteatosis grade 3)]. These mice were previously 
used in various experimental models to induce fatty liver. Figure 3-2 shows representative 
H&E stained sub-slides of each grade type. 
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Figure 3-2 : Representative Hematoxylin and Eosin images of different models used to induce fatty 
liver. A. Normal liver in wild type mouse fed chow diet. B. Mild fatty liver in wild type mouse fed 
high fat diet. C. Moderate fatty liver in GFP-LC3 mouse fed alcohol. D. Severe fatty liver in GFP-
LC3 mouse fed high-fat high-carbohydrate diet. 
 
All animal experimental protocols were approved by the Institutional Animal Care 
and Use Committee of Indiana University (IACUC). Animals were housed under approved 
conditions with 12 hour light dark cycle. C57BL/6 wild type and GFP-LC3(26) were bred 
in house. At 10 weeks of age, mice were placed on normal chow diet to produce normal 
liver, high fat diet (diet D12492, Research diets) to produce mild fatty liver or high-fat 
high-carbohydrate (HFHCD) diet, or chronic alcohol (29-36%) to produce moderate to 
severe fatty liver. For HFHCD diet, mice were given high fat diet along with the drinking 
water enriched with high-fructose corn syrup equivalent to a total of 42 g/L of 
carbohydrates. Drinking solution was made by mixing in drinking water at a ratio of 55% 
fructose (Acros Organics, Morris Plains, NJ) and 45% sucrose (Sigma- Aldrich, St. Louis, 
MO) by weight. Animals were provided ad libitum access to these diets for 10-24 weeks. 
Only liver biopsy slides from prior concluded studies were utilized for this study. Mice 
were first given Avertin (250 mg/kg, i.p.) for anesthesia, followed by cervical dislocation 
for euthanization. This procedure minimizes any suffering. All procedures are approved by 
the IACUC of Indiana University. 
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Liver biopsy H&E stained slides were studied and scored by the pathologist Dr. C 
according to NASH Clinical Research Network scoring system where steatosis grade range 
between 0-3 ( 0 < 5% steatosis , 1 = 5% - 33%, 2 = 33% - 66%, and 3 > 66% ) (27). 
  
 
Figure 3-3 : Pictorial representation of number of mice liver biopsies graded by Dr. C. 
 
b) Human Liver Biopsies 
  This experimental study chooses from 66 human liver biopsies. Both the 
pathologists mentioned below in Section 3.3, namely Dr. K and Dr. C, provided semi-
quantitative grades for the human liver biopsies. Dr. K graded 64 of the available 66 liver 
biopsies, however, Dr. C graded all the present human liver biopsies. Figure 3-5 and Figure 
3-6 show the bar graph representation of different patients affected with each histological 
feature of NAFLD based on the both the experts’ semi-quantitative grades. For this study, 
the H&E stained liver biopsies are used for detection of lobular and portal inflammation 
and correlated with the pathologist grades, and the TC stained liver biopsies are used for 
the detection of different types of fibrosis. There are 11 slides which are not affected by 
NAFLD. These human liver slides were previously used for experimental study as well. 
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Figure 3-4 : Pictorial representation of number of human liver biopsies graded by Dr. K. 
 
 
Figure 3-5 : Pictorial representation of number of human liver biopsies graded by Dr. C. 
 Image Data  
To obtain the digitized images, the biopsy slides are scanned at 20X using Aperio Scan 
Scope CS system. The scanned images are stored in SVS file format. These are based on the TIFF 
format of images at multiple resolutions and utilizes the tile image capabilities. They use 
compression type 33005 (which is a specific kind of JPEG 2000 compression for RGB format). 
Each SVS file received contains different types of images. The first one is termed as the 
“baseline version of the image” i.e. contains the full resolution version of the image. The second 
image is generally a thumbnail version, typically having dimensions of about 1024 × 768 pixels 
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which is always stripped. All the remaining versions of the image are pyramid images (each having 
lower resolution than the previous by a factor of 2 in each dimension), which are compressed with 
the same type of compression as that of the baseline image, organized as tiles with same tile size. 
The last two version of the image however, is a slide label image which contains lower resolution 
of either the slide label or the slide itself. Our research involves extraction of the highest resolution 
image (in JPEG format) and using a 50% reduced version of it, which enables us to speed up our 
image processing activities.  
 Pathologist Grades and Annotations 
  This study involves getting expert pathologists to grade the biopsy slide based on the 
NASH scoring system and also annotate different histological features in liver biopsy images. In 
this study, two pathologists provided the annotations and semi-quantitative grades for the liver 
biopsy slides. The different biopsy images include both a TC Stained and H&E Stained variants, 
such that the former is used for labeling and grading fibrosis content while the latter is used for 
labeling and grading steatosis, inflammation and ballooning content. The pathologists are Dr 
David E. Kleiner and Dr Oscar W. Cummings. Dr. David E. Kleiner, M.D., Ph.D. currently heads 
the Histopathology and Autopsy Pathology department at the Center of Cancer Research at 
National Cancer Institute in National Institute of Health (NIH) located at Bethesda, Maryland, 
United States (referred as Dr. K in this study). Dr. Oscar W. Cummings, M.D. is a Professor of 
Pathology and Laboratory Medicine and the Director of Surgical Pathology at Indiana University 
School of Medicine located at Indianapolis, Indiana, United States (referred as Dr. C in this study). 
All experiments conducted in this study to build different decision support systems to detect 
various histological features in a liver biopsy use both the above mentioned pathologists’ 
annotations for building machine learning models and their semi-quantitative grades for 
correlation. 
3.3.1 Annotation Tool 
One of the most important steps in this research involves gathering data from the expert 
pathologists. A web annotation tool had been built to annotate slide images and store the 
annotations (11). This tool is built using HTML5 and javascript open source technologies like 
Open Layers (currently under BSD License), which provides application programming interfaces 
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(APIs) to build rich web-based applications and Bootstrap (v3) which enhances the look and feel 
of the tool by providing responsive HTML and CSS enhancements.  
Vanderbeck et al in his study (7-9) had developed a web application for getting annotations 
from the experts. However, only small scaled images could be used to accomplish the same. 
Because of the size of our high resolution liver biopsy slides, that application could not be used. 
The markers associated with the tool were not user friendly and very large images take a lot of 
time to load. Later, Morusu et al. in her study (5, 6) developed a web application tool which 
addresses some of the above mentioned issues. In her study, she used the Open Layers API to load 
very large images at a quicker pace, such that images are divided into different set of tiles, and 
only the required set of tiles were loaded during annotation. However, the tool lacked some 
functionality in the labeling of TC Stained samples with different levels of fibrosis and the usability 
of the tool was not possible in different resolution monitors and browsers. Apart from this, the 
above mentioned tool had different setups for mice liver biopsies and human liver biopsies. To 
overcome all the above mentioned challenges, a responsive user interface (using Bootstrap library) 
has been added so that different type of screen resolutions do not hinder the usage of the tool. 
Along with the list of annotation labels mentioned by Morusu et al., new labels have been added 
for TC stained images to identify many more histological features which help uniquely identify 
the respective types. Figure 3-6 and Figure 3-7 give an overview of the newly built annotation tool.  
 In adherence to Morusu et al.’s idea (5, 6) of annotating slides two ways, the newly built 
annotation tool thus provides, point annotations as well as polygon annotations. Additionally, there 
is a newly added subset of polygon annotations, termed as square annotations which are used to 
identify the different types of fibrosis. This eases the work for the pathologist to draw a regular 
polygon, instead provides with an in-built square with a feature to expand the same. Flat files 
(unique by the combination of the image name and pathologist username), are used to save the 
annotations at the back end. 
 There are point annotations which are used to annotate relatively distinct areas of the image 
i.e. regions which have a specific shape, and structure. Therefore, the coordinates of the point are 
stored along with the anatomical/histological structure it defines is written in a file at the back end. 
 There are polygon annotations which are also known as boundary annotations, that enable 
the pathologist to annotate structures which have irregular shapes, but are convex in nature. Each 
click creates an edge in the polygon as we go along annotating it, a double click indicates that the 
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region is identified. Hence, the coordinates along each edge are recorded apart from the number 
of edges and the anatomical/histological structure it defines in a file at the back (server) end. 
 There are special type of polygon annotations introduced termed as square annotations, 
which allows the user to annotate areas in an expandable square format. This type of annotation 
has been introduced to ease the adding of an annotation. Thus, the coordinates along each edge are 
recorded with a fixed number of edges (=4) and the anatomical/histological structure it defines at 
the back end.  
Annotation 
Name 
Annotation 
Type 
Description 
Annotation 
Color 
Macro Fat Point 
Distinct globular white regions, 
generally in circular structure. 
Magenta 
Micro Fat Polygon 
Soapy textured white regions, 
spread across the biopsy area. 
Dark Blue 
Normal 
Fibrosis 
Square 
Polygon 
Blue regions around the 
inflammation area. 
Yellow 
(Fill) 
Pericellular 
Fibrosis 
Square 
Polygon 
Coarse chicken wired blue region 
structures around the cell areas.  
Red (Fill) 
Portal 
Fibrosis 
Square 
Polygon 
Blue regions around the portal vein 
areas. 
Aqua (Fill) 
Periportal 
Fibrosis 
Square 
Polygon 
Extension of blue regions around 
portal fibrosis. 
Purple (Fill) 
Bridging 
Fibrosis 
Square 
Polygon 
Continuous flow of blue regions 
spread across bile duct and any vein. 
Lime (Fill) 
Nodules 
Square 
Polygon 
Elliptical structures of comprising 
of blue region borders. 
Teal (Fill) 
Hepatocyte 
Ballooning 
Polygon 
Dark region areas across which 
appears with wispy cytoplasm. 
Magenta 
Lobular 
Inflammation 
Polygon 
Dark region areas which show 
inflammatory nuclei. 
Teal 
Portal 
Inflammation 
Polygon 
Dark region areas showing 
inflammatory nuclei in portal 
regions. 
Lime 
 
 As discussed by Morusu et al.(5, 6) in her study, the Table 3-1 presents a list of the current 
supported histological/anatomical structures in a liver biopsy. Each of the structures have a type 
of color associated with them in the annotation tool in order to differentiate them from one another. 
Table 3-1 : The different types of annotations present in the web annotation tool. 
23 
 
There are two figures – Figure 3-6 and Figure 3-7 that demonstrate point and boundary annotation 
examples in a mice liver biopsy and some square annotations in a human liver biopsy, respectively. 
 
Figure 3-6 : A Preview of the mice liver labeling tool with point and boundary annotations labeled 
at 6x magnification. 
 
 
Figure 3-7 : A Preview of the human liver labeling tool with square annotations (fibrosis 
annotations) labeled at 6x magnification. 
a. NAFLD Lesions:  The set of annotations in Tables 3-2 and 3-3 constitute the histological 
features in the liver biopsy which are essential to determine if a person is affected with 
NAFLD. Fibrosis and its types are present only in TC stained liver biopsies. 
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Tables 3-2 and 3-3 show the number of annotations provided by the expert pathologist(s) 
(Dr. C) in mice liver and (Dr. C and Dr. K) in human liver biopsies.  
 
Table 3-2 : The number of NAFLD lesion annotations present for mice liver biopsies. 
Annotation 
Name 
Annotations – Dr. C 
Macro Fat 22696 
Micro Fat 568 
Hepatocyte 
Ballooning 
0 
Lobular 
Inflammation 
40 
Portal 
Inflammation 
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Table 3-3 : The number of lesion annotations present for human liver biopsies. 
Annotation 
Name 
Annotations – Dr. C Annotations – Dr. K 
Total 
Annotations 
Macro Fat 952 359 1311 
Micro Fat 0 12 12 
Normal 
Fibrosis 
0 186 186 
Pericellular 
Fibrosis 
126 128 254 
Portal 
Fibrosis 
2 118 120 
Periportal 
Fibrosis 
46 127 173 
Bridging 
Fibrosis 
41 98 139 
Nodules 54 61 115 
Hepatocyte 
Ballooning 
11 92 103 
Lobular 
Inflammation 
260 347 607 
Portal 
Inflammation 
163 340 503 
 
b. Anatomical Structures in liver biopsy: The set of annotations in Table 3-4 constitute the 
different anatomical structures present in a liver biopsy. 
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Annotation 
Name 
Annotation 
Type 
Description 
Annotation 
Color 
Bile Duct Polygon 
Ring - like white region structures, 
generally with nuclei. 
Orange 
Central Vein Polygon 
White region structure around the 
center of a lobular area. 
Green 
Portal Artery Polygon 
White regions showcasing a thick 
arterial wall. 
Aqua 
Portal Vein Polygon 
White regions in general. A blood 
vessel which carries blood from 
different areas around to the liver.  
Blue ring 
(with red 
fill) 
Sinusoid Point 
White region generally, blood vessel 
between hepatic artery and portal 
vein 
Yellow 
 
Table 3-5 shows the number of annotations provided by the expert pathologist (Dr. C) in 
mice liver. Table 3-6 shows the number of annotations provided by both pathologists (Dr. 
C and Dr. K) in human liver biopsies.  
 
Table 3-5 : The number of annotations present for mice liver biopsies. 
Annotation 
Name 
Annotations – Dr. C 
Bile Duct 121 
Central Vein 117 
Portal Artery 22 
Portal Vein 75 
Sinusoid 39 
 
 
 
 
Table 3-4 : The different anatomical structures present in a liver biopsy. 
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Table 3-6 : The number of annotations present for human liver biopsies. 
Annotation 
Name 
Annotations – Dr. 
C 
Annotations – Dr. K Total Annotations 
Bile Duct 43 115 158 
Central Vein 13 50 63 
Portal Artery 32 72 104 
Portal Vein 37 80 117 
Sinusoid 314 173 487 
 
c. Control Tissues: The tissue areas which serve as normal regions or areas where the disease 
is not present (Table 3-7). 
Annotation 
Name 
Annotation 
Type 
Description 
Annotation 
Color 
Normal 
Hepatocyte 
Polygon 
Liver cells – occupy 80% of the 
liver in general. 
Red 
Normal 
Parenchyma 
Polygon 
Group of liver cells which perform 
a particular activity. 
Aqua ring 
(with orange 
fill) 
 
Tables 3-8 and 3-9 show the number of annotations provided by the expert pathologist(s) 
(Dr. C) in mice liver and (Dr. C and Dr. K) in human liver biopsies. 
 
Table 3-8 : The number of annotations present for mice liver biopsies.  
Annotation 
Name 
Annotations – Dr. C 
Normal 
Hepatocyte 
10 
Normal 
Parenchyma 
6 
 
 
 
Table 3-7 : The different types of control tissues. 
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Table 3-9 : The number of annotations present for human liver biopsies.  
Annotation 
Name 
Annotations – Dr. C Annotations – Dr. K Total 
Annotations 
Normal 
Hepatocyte 
1 52 53 
Normal 
Parenchyma 
0 11 11 
 
d. Others:  These are the areas which are incorporated due to the process involving in taking 
a liver biopsy and preparing the slides (Table 3-10). These account for negative classes in 
our study.  
 
 
Annotation 
Name 
Annotation 
Type 
Description 
Annotation 
Color 
Tissue 
Preparation 
Tear 
Point 
Tissue tear during tissue 
preparation. Generally white region. 
Orange 
Tissue 
Preparation 
Stretch 
Point 
Tissue stretch during tissue 
preparation. Generally white region. 
Dark Blue 
Slide 
Background 
Point The non-tissue area in the slide. Lime 
Tissue Fold Point 
Tissue fold during tissue 
preparation. 
Green 
Squame Point Structure damage in tissue. Aqua 
Other Point 
Any other structure apart from the 
above mentioned ones. 
Red 
 
Tables 3-11, 3-12, and 3-13 show the number of annotations provided by the expert 
pathologist(s) (Dr. C) in mice liver and (Dr. C and Dr. K) in human liver biopsies. 
 
 
 
 
 
 
Table 3-10 : A few histological areas incorporated while taking a liver biopsy. 
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Table 3-11 : The number of annotations present for mice liver biopsies. 
Annotation 
Name 
Annotations – Dr. C 
Tissue 
Preparation 
Tear 
22 
Tissue 
Preparation 
Stretch 
11 
Slide 
Background 
0 
Tissue Fold 47 
Squame 39 
Other 5 
 
Table 3-12 : The number of annotations present for human liver biopsies. 
Annotation 
Name 
Annotations – Dr. C Annotations – Dr. K Total 
Annotations 
Tissue 
Preparation 
Tear 
49 102 151 
Tissue 
Preparation 
Stretch 
0 0 0 
Slide 
Background 
0 59 59 
Tissue Fold 12 25 37 
Squame 0 1 1 
Other 6 15 21 
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Table 3-13 : Cumulative number of annotations available on mice and human. 
Type of 
Structure 
Mice Human 
Total 
Annotations 
NAFLD 
Lesions 
2932 3523 6455 
Anatomical 
Structures  
16 64 80 
Control 
Tissues 
374 929 1303 
Other 124 269 393 
 Steatosis Classification 
The detection of steatosis can be of two types, namely, macrosteatosis (also known as macro fat) 
and microsteatosis (also known as micro fat).  
3.4.1 Macro Fat Detection 
  A supervised machine learning model is trained using various regions which have a white 
center: macrovesicular steatosis, microvesicular steatosis, bile duct, portal artery, portal vein, and 
central vein. 
 
Figure 3-8 : White regions in mouse liver biopsy.  
Once the model identifies macrosteatosis regions among the other white regions, the percentage 
of macrosteatosis is calculated based on the area of tissue identified as fat. This value is then 
correlated with the semi-quantitative grade provided by the pathologist. 
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The processing steps in the identification and quantification of macrosteatosis are shown below. 
More detailed explanation of each step is given as follows. 
 
a) Identifying the tissue region: A region growing algorithm is applied on the green channel 
of the 50% reduced RGB image to separate the tissue and background regions.  
b) Identifying the white regions: The intensity image obtained from the green channel is 
filtered using a 3x3 averaging mask in order to smooth out noise. The intensity values in the image 
are then adjusted with a GAMMA correction value of 6 to make the image darker. K-means 
clustering is applied to the darkened image with a k value of 2 (i.e., 2-clusters are identified). Pixels 
in the image are now divided into two classes, white and black. Any white region bigger than 60 
pixels is eliminated and the remaining white regions are used as starting points for further analysis.  
d) Obtaining the feature vector for each white region: For each of the white regions 
obtained using the previous step, image features are computed to be used in learning the model. 
The details of the types of attributes extracted are further explained below in the Section on Feature 
vector representation. 
e) Annotations:  The computed feature vectors of regions annotated by the pathologist are 
used as training patterns for learning the model. There are two types of annotations provided by 
the pathologist: points and polygonal regions. For point annotations, the individual white region 
on which the point is marked is considered. For polygonal annotations all the white regions falling 
within the given polygonal boundary annotation are considered and processed. Figure 3-10 shows 
a graphic with white and dark regions, point and polygon annotations. The white regions within a 
polygon pointed to by arrows in the Figure 3-10 are used for feature extraction for the label 
represented by the polygon. Similarly, the white region pointed to by point annotation is used for 
extracting attributes for the given label.  
f) Learning the model:  Support vector machine (SVM) with a linear kernel is the machine 
learning technique used for learning the model for macrosteatosis identification from the expert 
pathologist’s annotations of several regions.  
g) Macrosteatosis Identification: Once the trained classifier model is ready, new (i.e., 
previously unseen) images are processed using the trained classifier: feature vectors are computed 
for all white regions and are used to classify each of the white regions, resulting in the identification 
of macrosteatosis. 
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Figure 3-9 : Overall flow diagram of the approach to automated macrosteatosis identification and 
quantification. 
 
 
Figure 3-10 : Graphic showing dark and white regions with point and polygon annotations. The 
white region labeled using point annotation (represented using 'X') is used for extracting attributes. 
A polygon annotation is shown using black polygon. The white regions falling within the polygon 
are indicated by arrows and these are the regions used for attribute extraction for the given label. 
3.4.2 Micro Fat Detection 
  As shown in Figure 3-8, microsteatosis could display different histological appearances on 
H&E stained liver biopsies, from very tiny cytoplasmic vesicles, to small cytoplasmic vesicles that 
do not displace the hepatocyte nucleus, to a foamy appearance of the cytoplasm. A supervised 
machine learning model is trained using various regions: microvesicular fat, macrovesicular fat, 
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bile duct, portal artery, portal vein, central vein and sinusoid. This trained model is then used to 
identify the microsteatosis regions in the image among the other identified regions.  
The processing steps in the identification of microsteatosis are shown in Fig 3-11. More 
detailed explanation of each step is given below. 
a) Obtaining the image: The digital image from the Aperio Scan Scope CS system is stored 
in Aperio svs format. The resolution picked from svs format file is the 50% reduced one. 
b) Identifying the tissue region: A region growing algorithm is applied on the green channel 
of the 50% reduced RGB image to separate the tissue and background regions.  
c) Obtaining feature vector for region (pixel wise): For each of the images generated after 
isolating the tissue area as described in step (b), Gabor filter based texture features are computed. 
The details of the feature extraction are further explained below in Section 3.4.3 on Feature vector 
representation. 
d) Annotations:  The computed feature vectors of regions annotated by the pathologist are 
used as training patterns for learning the model. In the web-based annotation tool, the 
microsteatosis regions are denoted by the pathologist by drawing a polygon around the regions. 
The pixels falling within these annotated polygons are labeled as microsteatosis and the computed 
features for these pixels are used for training the model. Because the number of such pixels is too 
large, in order to reduce the computation time for the training phase, we randomly subsampled 
0.02% of the pixels annotated as microsteatosis and 0.001% of the pixels annotated as any other 
histological feature. 
e) Learning the model:  SVM with a linear kernel is the machine learning technique used 
for learning the model for microsteatosis identification from the expert pathologist’s annotations 
of several regions.  
f) Microsteatosis identification: Once the trained classifier model is ready, new (i.e., 
previously unseen) images are processed using the trained classifier: feature vectors based on 
Gabor texture features are computed for all regions which are then used to classify them as 
microsteatosis or non-microsteatosis regions. 
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Figure 3-11 : Overall flow diagram of the approach to automated microsteatosis identification. 
 
3.4.3 Feature Vector representation 
  In prior studies presented by Vanderbeck et al. (7-9) and Morusu et al. (5, 6, 11), we used 
image texture statistics at various scales (σ = 0,1,2,4,8) as feature vectors to be used as input to the 
classifier. In this study, we have extended this feature set to improve the accuracy of identification. 
“We added a new set of textural features using Gabor filters (28, 29) in detected white regions or 
in annotated macrosteatosis regions. For each of the white regions, the surrounding area of 20 
pixels in all directions is considered for extracting these attributes. Also, a rectangular region of 
25 pixels around the white region is considered for feature extraction.  
Gabor filters, which are band pass filters at various frequencies and orientations, are used 
in this study for texture analysis. The impulse response of a Gabor filter is the product of a 
sinusoidal plane wave at a given frequency (𝑓 = 1 𝜆⁄ ) and orientation (𝜃) with a Gaussian function 
at a given scale (𝜎). 
The equation of Gabor function in spatial domain is given below (30-33): 
𝑔(𝑥, 𝑦; 𝜆, 𝜃, 𝜓, 𝜎) = exp (−
𝑥′2 + 𝑦′2
2𝜎2
) exp (𝑖 (2𝜋
𝑥′
𝜆
+ 𝜓)) 
where 𝑥′ = 𝑥 cos 𝜃 + 𝑦 sin 𝜃  and 𝑦′ = −𝑥 sin 𝜃 + 𝑦 cos 𝜃,  are the rotated coordinates to account 
for the filter orientation, 𝜆 = 1 𝑓⁄  is the period of the sine wave, 𝜃 is the orientation of the Gabor 
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filter, 𝜎 is the width of the  Gaussian envelope, 𝜓 is the phase offset of the sine wave, and 𝑖 =
√−1. Thus, the function 𝑔(𝑥, 𝑦; 𝜆, 𝜃, 𝜓, 𝜎) defines the convolution kernel. Filtering is performed 
in the frequency domain using fast Fourier transforms as it is computationally faster. 
In the macrosteatosis identification, we have used four orientations ( 𝜃 =
0°, 45°, 90°, and 135°) for the Gabor filters and for each orientation five radial frequencies which 
are one octave apart, for a total of 20 Gabor filters (4 orientations × 5 frequencies) (34). These 
filters are applied to 7 images (3 for RGB channels separately, 3 for HSV channels separately and 
one for the gray level image) resulting in a total of 140 Gabor filter features.” (5, 6) 
These, combined with the features from our prior study (35), results in a total of 554 
features which have been used in training the classifier.  
In the microsteatosis identification, we have used four orientations ( 𝜃 =
0°, 45°, 90°, and 135°) for the Gabor Filters and for each orientation ten radial frequencies which 
are one octave apart, for a total of 40 Gabor filters (4 orientation × 10 frequencies)  (34). These 
filters are applied to a single image (gray scale), resulting in 40 Gabor filter features for each pixel. 
3.4.4 External Validation of Classifier’s Accuracy 
To verify the accuracy of the classifiers identifications of lesions as macro- or 
microsteatosis, liver biopsy images previously unseen by the classifiers that have not been used in 
the training of the classifier were used in this step.  
For macrosteatosis validation, fifty randomly identified macrosteatosis lesions were 
selected and classified using the automated algorithm. These classification results were examined 
by the study pathologist to determine the validity of the identification.  
For microsteatosis validation, one hundred and ten random sub slides from a pool of 
eleven previously unseen slides were examined by the study pathologist to determine the validity 
of the identification. We used a larger number of microsteatosis identified lesions for validation in 
order to properly represent the slides based on the significantly smaller size of these lesions 
compared to macrosteatosis lesions. The study pathologist assessed each identified (microsteatosis 
or not microsteatosis) lesion by the classifier as correct or incorrect. Accuracy was calculated as 
percent correctly identified with macro- or microsteatosis by the classifier as determined by the 
gold standard, the study expert pathologist. 
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3.4.5 Quantification of Macro Fat 
After macrosteatosis regions are identified by the trained classifier, the percent area of 
macrosteatosis in a biopsy image was quantified. Pathologists provide semi-quantitative 
macrosteatosis grade based on their perception of percentage macrosteatosis area. And hence, in 
this study, the ratio of measured macrosteatosis area to the total tissue area is calculated as a 
continuous measure of macrosteatosis quantification so that it can be compared with pathologist’s 
semi-quantitative grades. For each of the white regions, the area is already calculated as part of 
computing the morphological features. The sum of areas of all white regions identified by the 
classifier is the macrosteatosis area. The tissue area is computed by using the background mask 
extracted in the white region identification process. The image area in the regions where mask is 
not present is considered as tissue and the space occupied by this region in pixels is the tissue area. 
 Inflammation Classification 
The identification of inflammation areas include the detection and quantification of each of 
the lobular and portal inflammation. This section describes the process of doing the same. 
3.5.1 Lobular and Portal Inflammation Detection 
  This research is an extension of the study done by Morusu et al. to detect inflammation in 
human liver biopsies (5, 6). As addressed in the above study, this involves detection of the different 
dark regions associated to a liver biopsy sample. The various histological features that are 
generally referred to as dark regions include, lobular inflammation, portal inflammation, normal 
hepatocyte and bile duct. 
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Figure 3-12 : The different dark regions present in a liver biopsy slide. 
 
  The Figure 3-12 shows the each of the different dark regions taken for this study. Here, we 
try to improve the existing models built for lobular and portal inflammation detection by reducing 
the classes that are not affected much, such as micro fat, tissue folds, normal parenchyma and 
hepatocyte ballooning. The same processing techniques (explained by Morusu et al. (5, 6)) are 
applied and a supervised machine learning model is created with the above four mentioned 
features.  
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3.5.2 External Validation of Classifier’s accuracy 
In order to verify the accuracy of detection of the built machine learning classifier for both 
lobular and portal inflammation, unseen liver biopsy samples which have not been used as part of 
the training set to build the classifier have been used.  
 To detect the lobular inflammation, there are 113 sub slides selected in random from a set 
of 16 liver biopsy slides which are processed and evaluated by the classifier to detect the presence 
of lobular inflammation. The results from the classifier are then examined by the expert 
pathologists to determine the correctness of the classifier built. 
 For the portal inflammation detection, there are 110 sub slides selected in random from a 
set of 16 liver biopsy slides which are then processed by the built classifier to detect the portal 
inflammation areas. These areas are then evaluated by the expert pathologists to determine the 
accuracy of the classifier. The accuracy of the classifier is computed based on the ratio of number 
of correctly classified instances by the total number of instances processed by the classifier as 
determined to the pathologists’ “gold standard”.  
3.5.3 Quantification of Inflammation 
  Once the inflammation regions are identified by the classifier built, the percentages of both 
lobular and portal inflammation areas in a biopsy image are quantified. The expert pathologists 
provide semi-quantitative grades based on their perception of the infected portal and lobular 
inflammation areas. Therefore, in this research, the ratio of measured portal and lobular 
inflammation area to that of the tissue is computed and thereby compared to the expert 
pathologists’ grades. For each of the dark region computed, the area is computed based on the 
morphological features calculated. The tissue mask area is the actual area in the slide with the 
tissue present (computed in the step 2 of the process). 
 Fibrosis Classification 
In our study, we look to build a new classifier which detects if fibrosis is present in a liver 
biopsy. Apart from this, we also build different classifiers to identify the various types of fibrosis 
which include, normal fibrosis, pericellular fibrosis, portal fibrosis, periportal fibrosis, bridging 
fibrosis and cirrhosis by analyzing the various blue regions in the image, also known as collagen. 
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Fibrosis is the blue region area present in a TC Stained liver biopsy. Based on their 
morphological structures, textural properties and their surrounding neighborhood, they are 
identified as different types of fibrosis. While building the model, all labels which have blue 
regions associated with the annotated slide are fed to the classifier. During the model’s training 
phase, the annotated area’s neighborhood is also analyzed, apart from present annotated region. 
As the classifier gets built, unseen samples are passed to the model which in-turn detect the kind 
of fibrosis present. The amount of blue region (collagen) is correlated with the pathologist grades 
as well. The severity of fibrosis is detected based on the following table. Based on the number of 
nodule regions and the bridging regions, followed by the percentage(s) of other types of fibrosis 
like, portal fibrosis, periportal fibrosis, pericellular fibrosis and normal fibrosis, we correlate them 
with the semi-quantitative grade provided by the pathologists. 
Different types of fibrosis classes are listed below along with their diagrammatic 
representation. 
1. Normal Fibrosis: The blue regions around the inflammatory nuclei (dark regions which 
are diffusely scattered). Figure 3-13A shows an example of Normal Fibrosis. 
2. Pericellular Fibrosis: The chicken wire shaped blue regions which are very thin around 
the cell. These extend along sinusoids to surround one or a group of hepatocytes. Figure 3-
13B shows an example of Pericellular Fibrosis. 
3. Portal Fibrosis: The blue regions present around the portal triad region are termed Portal 
Fibrosis, which consequently become densely stained and expanded around those regions, 
however, there is no extensions to its adjacent parenchyma. Figure 3-13C shows an 
example of Portal Fibrosis. 
4. Periportal Fibrosis: The blue regions present around the periportal triad region are termed 
as Periportal Fibrosis, there can be extensions to its neighboring parenchyma. Figure 3-
13D shows an example of Periportal Fibrosis. 
5. Bridging Fibrosis: The connective blue strands present across the tissue connecting 
various portal tracts and central veins. They are continuous in nature. Figure 3-13E shows 
an example of Bridging Fibrosis.  
6. Cirrhosis (Nodule):  The blue region strands which when connected, form a regular 
elliptical structure is termed as Nodule or Cirrhosis. This type of fibrosis is widely 
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distributed therefore, the resultant morphological structure appearance encompass a wide 
spectrum. Figure 3-13F shows an example of Nodule. 
 
 
Figure 3-13 : Different types of fibrosis annotated. A. Normal Fibrosis B. Pericellular Fibrosis C. 
Portal Fibrosis D. Periportal Fibrosis E. Bridging Fibrosis F. Nodule. 
 
There are a number of classifiers built during this process. Firstly, there is one classifier 
we build with two classes namely, Normal Fibrosis (represented in Figure 3-14A) and abnormal 
fibrosis. The abnormal fibrosis classes consists of all the remaining types of fibrosis ranging from 
pericellular fibrosis, portal fibrosis, periportal fibrosis, bridging fibrosis, cirrhosis. Apart from this 
classifier, there is another one which contains pericellular fibrosis, portal fibrosis, periportal 
fibrosis and bridging fibrosis. The third classifier built has two classes namely, nodules and others 
where others constitute pericellular fibrosis, portal fibrosis, periportal fibrosis and bridging fibrosis. 
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3.6.1 Blue region Extraction 
The first step involved in identification of different types of fibrosis involves blue region 
extraction from a TC Stained image. The following are the steps involved in extracting the collagen 
in a liver biopsy. Figure 3-14 gives a pictorial representation of the same. 
a. Image Retrieval: The TC Stained image is obtained in Aperio svs format. The image is 
then processed in the 50% scaled version of it. 
b. Identification of Tissue: In order to identify the tissue area, an 8-bit gray scale image is 
created. This distinguishes the tissue area sample from the image background and this is 
done by forming a weighted sum of the R, G and B components using the following 
formula:  𝑔𝑟𝑎𝑦 = 0.2989  𝑅 +  0.5870 𝐺 +  0.1140 𝐵  (36) The gray image is then 
subjected to global thresholding using Otsu’s method (37). This threshold is then applied 
on the image to get a black and white image, such that the tissue area is highlighted in white 
and background is masked out accordingly.  
c. Identification of blue regions: The tissue mask calculated in the previous step is then 
applied on the TC Stained image such that processing can take place only on the required 
tissue area. The newly formed TC Stained image is then subjected thresholding based such 
that the blue channel pixels range from 0.6863 to 0.9411 of a normalized intensity range 
(normalized to the range [0,1]), red and green channel pixels range from 0.2941 to 0.8235, 
respectively in the normalized intensity range. 
d. Building supervised models: There are various features thus computed for unique 
identification of different kinds of fibrosis, a supervised machine learning model is built 
using support vector machines (SVM) and therefore, the model is evaluated using 10-fold 
cross validation. The different blue regions extracted belong to one type of fibrosis, each 
of them are separately built using two classes (type of fibrosis and others), due to the 
variable set of annotations present, sub-sampling is done. 
41 
 
 
Figure 3-14 : The figure shows the pictorial representation of the steps involved in extracting the 
collagen in a liver biopsy. 
 
3.6.2 Attribute vector representation 
For each of the blue regions extracted by using the steps in section 3.6.1 different types of 
features are calculated. The blue regions, and their surrounding area of 20 pixels in all directions 
are also computed. The details of each of the following set of attributes is listed below. 
 Histogram of oriented gradients (HOG): Histograms of Oriented Gradients (HOG) is 
one of the well-known features for object recognition. HOG features are calculated by 
taking orientation histograms of edge intensity in a local region (38). The basic idea of 
these features is that the distribution of local intensity gradient orientations will capture the 
shape properties of the structure. This method is based on evaluating well-normalized local 
histograms of image gradient orientations in a dense grid (39). 
These features are useful, as they capture edge or gradient structure characteristic 
to the local shape in a local region with an easily controllable degree of invariance to local 
geometric and photometric transformations: translations or rotations make a little 
difference if they are much smaller than the local spatial or orientation bin size (39). 
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In this study, HOG feature extraction technique proposed by Dalal et al. is used (39, 
40). Following are the list of parameters specified for computing HOG descriptors such 
that they can be used to extract feature vectors which help in the unique identification of a 
blue point.  
1. Cell Size: This resembles the size of each extracted HOG cell. We have used 8X8 
so that even the smallest-scale detail is not to be missed. 
2. Block Size: This corresponds to the number of cells associated to one block. 
Smaller block sizes enable us to capture the significance of local pixels and so we 
have used a block size of 1X1. 
3. Block Overlap: This parameter is used to set the number of overlapping cells 
between two adjacent blocks. The larger the overlap, the more number of features 
are generated. In our case, as we have a block size of one already set (point based 
extraction), there is no overlap. 
4. Number of orientation histogram bins: For our experiment, we choose 9 bins. 
These HOG descriptors are computed for each of the blue pixels in a 70X70 sub-slides. 
 
 Speeded up robust features (SURF): These features comprise of different phases 
involving feature extraction, feature description and feature matching. One main advantage 
associated with detection of SURF features is that, it is very fast in terms of computational 
time. The focus of these set of features is to get various scale and in-plane rotation invariant 
detectors and descriptors. It strikes the right balance among different feature complexities 
and robustness to the common photometric deformations. An input image is thus analyzed 
to get different point features, followed by analyzing the same at different scales and 
determining interest points which can uniquely identify its surrounding area. These set of 
interest points are then subjected to get a rotation and scale invariant descriptor for itself 
(41). 
  For this study SURF is applied to determine various blob features present in an 
image, which will eventually be used to determine different types of fibrosis, especially 
nodules due to their varying shape and size. Following are the list of parameters that can 
be provided to determine specific features for our use (41). 
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1. Metric Threshold: This is by default set to 1000.0. To determine as many as all 
the blobs present in the image, we can vary up to any extent higher. For this 
experiment, default values have been used as the areas of interest are computed in 
the previous step of blue region extraction itself. 
2. Number of Octaves: If the goal of the experiment is to determine only distinctly 
huge blobs, the number of octaves can be increased. For our experiment, the default 
value of 3 is used. 
3. Number of Scale levels: This determines the number of different scales at which 
the features are to be computed. In our study, four different scales are computed to 
uniquely determine nodules. 
4. Rectangular region of Interest: This is the set of points on which the computation 
is focused. For our experiment, we use the blue region areas (represented as two 
dimensional coordinates) within the annotated region in a liver biopsy. 
 
 Gabor features: In this study, to uniquely identify a blue pixel in a liver biopsy sample 
we compute Gabor features around the blue pixel (25X25 region surrounding it). The 
details of the Gabor feature implementation has already been explained in the section 3.4.3. 
3.6.3 Different types of Fibrosis Detection 
  In order to detect different types of fibrosis in a liver biopsy slide, this study involves 
building different machine learning models which detect normal and abnormal fibrosis. Further, 
in order to detect normal, portal, and periportal fibrosis – there are various morphological features 
that are computed along with texture based features like Gabor features, features computed based 
on derivatives across different scales. There are a total of 527 features computed for identification 
of portal fibrosis, periportal fibrosis and pericellular fibrosis. Apart from these, to detect nodules 
(cirrhosis) and bridging fibrosis in this study, SURF features along different scales and HOG 
features are computed as the uniqueness of a nodule can be determined across different scales. A 
total of 307 features are computed for two different models (one being nodule v/s others and the 
other bridging fibrosis v/s others). 
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3.6.4 Quantification of Collagen 
  Collagen accounts for the blue region present in a liver biopsy slide. Once the blue region 
extraction is done, the amount of blue region is computed. The expert pathologists provide semi-
quantitative grades for each of the validation slides, based on the collagen content and the nature 
of fibrosis present in a liver biopsy. In this study, the expert pathologists’ grades are quantified 
with the amount of collagen content (blue region area computed) basing on the weighted average 
sum of the blue region area to that of the tissue area.  
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4. RESULTS 
  This section involves the different results associated with the detection of steatosis, 
inflammation and fibrosis and its types. In this study, quantification of each of the different 
detected histological features are also studied and correlated by the expert pathologist grades. 
 Validation Metrics 
There are various kinds of metrics that can be used to uniquely validate a supervised machine 
learning classifier. In this study, we use the following different validation metrics. 
 
 Confusion Matrix: 
Confusion matrix is a layout used to describe the performance of a classification 
model. It contains the information about actual and classified data. It is a square matrix of 
order n where n is the number of classes with rows having the predicted classes and the 
columns having the actual classes. The following table gives an insight about the confusion 
matrix of order 2.(42) 
Table 4-1 : Confusion matrix of order 2. 
 Predicted 
negative 
Predicted positive 
Actual negative a b 
Actual positive c d 
 
a is the number of true negative predictions which is the number of classes correctly 
classified as negative. 
b is the number of false positive predictions which is the number of classes incorrectly 
classified as positive. 
c is the number of false negative predictions which is the number of classes incorrectly 
classified as negative. 
d is the number of true positive predictions which is the number of classes correctly 
classified as positive. 
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 Precision (p): 
  Precision is the proportion of correct positive classifications from the samples that 
are predicted as positive. In this case it measures the percentage of images correctly 
identified as having the disease among all the images identified as having the disease. 
By using the above example of confusion matrix, precision is calculated as follows 
𝑝𝑟𝑒𝑐𝑖𝑠𝑖𝑜𝑛 =  
𝑡𝑟𝑢𝑒 𝑝𝑜𝑠𝑖𝑡𝑖𝑣𝑒
𝑡𝑟𝑢𝑒 𝑝𝑜𝑠𝑖𝑡𝑖𝑣𝑒 + 𝑓𝑎𝑙𝑠𝑒 𝑝𝑜𝑠𝑖𝑡𝑖𝑣𝑒
=  
𝑑
𝑑 + 𝑏
 
 
 Recall (r): 
Recall is the ratio of the number of positive samples predicted as positive to the 
actual number of positive samples. In our case it measures the proportion of actual images 
with disease among the images identified as having disease. 
     
𝑟𝑒𝑐𝑎𝑙𝑙 =  
𝑡𝑟𝑢𝑒 𝑝𝑜𝑠𝑖𝑡𝑖𝑣𝑒
𝑡𝑟𝑢𝑒 𝑝𝑜𝑠𝑖𝑡𝑖𝑣𝑒 + 𝑓𝑎𝑙𝑠𝑒 𝑛𝑒𝑔𝑎𝑡𝑖𝑣𝑒
=
𝑑
𝑑 + 𝑐
 
 
 Receiver Operating Characteristic (ROC): 
  ROC is a graph plotted between True Positive Rate (also known as Recall) on Y 
axis against False Positive Rate on X axis. It depicts the relative tradeoffs between benefits 
(true positives) and costs (false positives) at various threshold settings. 
False positive rate is the ratio of the number of samples which are predicted incorrectly to 
the actual number of negative samples. From the above example of confusion matrix, False 
Positive Rate is calculated as follows - 
𝐹𝑎𝑙𝑠𝑒 𝑃𝑜𝑠𝑖𝑡𝑖𝑣𝑒 𝑅𝑎𝑡𝑒 =  
𝑏
𝑏 + 𝑎
 
Each point plotted in ROC is an ordered pair of Recall and False Positive Rate. A classifier 
has better performance characteristics if the curve is towards the upper left and close to X 
axis since it results in high value of Recall (43). 
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 Accuracy: 
  Classification accuracy is defined as the proportion of correct classifications among 
all classifications. It is calculated as the ratio of the sum of number of true positives and 
true negatives to the total number of samples. 
From the above example of confusion matrix, the accuracy is  
𝐴𝑐𝑐𝑢𝑟𝑎𝑐𝑦 =  
𝑎 + 𝑑
𝑎 + 𝑏 + 𝑐 + 𝑑
 
 
 F measure: 
  F1 score is the harmonic mean of Precision and Recall. It is a measure of accuracy 
of a classifier. High F measure indicates the best performance as both the precision and 
recall of the system are high. 
𝐹1 𝑠𝑐𝑜𝑟𝑒 =  
2 ∗ 𝑝 ∗ 𝑟
𝑝 + 𝑟
 
 Correlation: 
  Correlation defines the strength of association between two continuous variables. 
It is measured by a value called Correlation coefficient whose value typically lies between 
-1 and +1. The closer the value of coefficient to either -1 or +1 the stronger is the relation 
between both variables. Positive coefficient value indicates the directly proportional 
relation whereas the negative correlation value indicates the inversely proportional relation 
between the variables. 
Pearson Correlation Coefficient: 
  It is the ratio of the covariance of two variables to their product of the standard 
deviation where covariance of two variables is the expected value of the product of their 
derivations from their individual expected values. This coefficient gives more accurate 
values if the variables are normally distributed. 
𝑟 =  
∑ (𝑥𝑖 − 𝑥𝑚
𝑛
𝑖=1 )(𝑦𝑖 − 𝑦𝑚)
√∑ (𝑥𝑖 − 𝑥𝑚)2
𝑛
𝑖=1 ∗ ∑ (𝑦𝑖 − 𝑦𝑚)
2𝑛
𝑖=1
 
 𝑥𝑖 and 𝑦𝑖 are the individual values of variables x and y respectively. 
𝑥𝑚 and 𝑦𝑚 are the expected values (mean) of x and y respectively (44). 
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Spearman Correlation Coefficient: 
  Unlike the Pearson’s Coefficient, this coefficient does not assume that the variables 
are normally distributed. It defines the strength of monotonic relationship between two 
variables. The variables must be monotonically increasing or decreasing (If one variables 
increases, the second variable should never decrease and vice-versa) and not necessarily 
linear. It is obtained by performing Pearson Correlation Coefficient on the ranked variables. 
Ranking is done by assigning the lowest value of 1 and the next lowest 2 and so on. 
𝑟𝑠 =  1 −
∑ 𝑑𝑖
2𝑛
𝑖=1
𝑛(𝑛2 − 1)
 
𝑑𝑖 is the difference in ranks of x and y  
n is the number of samples of x and y 
 Steatosis 
I. Training Data 
The training data for learning the macrosteatosis model is the white regions 
annotated by Dr. C, including 2256 macrosteatosis annotations from 11 liver biopsy 
images. The training data for learning the microsteatosis model was polygonal regions 
annotated as microsteatosis by Dr. C, including 570 microsteatosis annotations from 5 liver 
biopsy images. 
 
II. Test Data 
  The test data to detect macrosteatosis comprises of 27 slides which provided with 
semi-quantitative grades given by Dr. C. The test data to detect microsteatosis comprises 
of 11 slides. These slides are processed and a random set of 10 sub-slides each identified 
as microsteatosis by the built classifier are validated by Dr. C. 
 
III. Detection and quantification results 
  In this study, the supervised machine learning models built to detect macrosteatosis 
and microsteatosis are subjected to 10-fold cross validation. The training data comprised 
of the annotated data given by the expert pathologists. All the present white regions could 
not be used for the building of this model as it involved a lot of overlapped annotations. 
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 For the macrosteatosis model, sinusoids and micro fat labels were not taken into 
consideration because their annotations had a few overlaps with the other set of white 
region classes and also, sinusoids were not extracted accurately during the white region 
extraction because they are very tiny set of white regions and may be ignored during the 
thresholding.  
  For the microsteatosis model, it consisted of only two classes namely, 
microsteatosis regions and non-microsteatosis regions. The non-microsteatosis regions 
comprise of all the other white region areas mentioned in the Table 4-2. Because of the 
irregularity/imbalance associated with the number of annotations (568 micro fat, 2296 
macro fat, 117 central vein, 121 bile duct, 75 portal vein and 22 portal artery), a random 
subset of annotated data are removed and the rest is used for training. The feature extraction 
is done pixel-wise and therefore, we randomly subsample 0.02% of the microsteatosis data 
and 0.001% of any other white region extracted feature. Evaluation of accuracy of macro- 
and microsteatosis identification was performed using a 10-fold cross validation in the 
training set. For macrosteatosis prediction, the model’s precision, recall (sensitivity) and 
area under the receiver operator characteristic (AUROC) were 94.2%, 95%, 99.1%, 
respectively.  The classifier’s accuracy was 84.2%.  
  When correlated with the pathologist’s semi-quantitative grade of macrosteatosis, 
the model fits with a coefficient of determination 𝑅2 value of 0.905. Figure 4-1 shows the 
2𝑛𝑑  order polynomial curve fitted to the data points. The strong correlation between 
quantitative results obtained by the algorithm developed in this study for estimating the 
percentage macrosteatosis and the pathologist macrosteatosis grades are shown in  
Figure 4-2 (p=0.01 after performing two-sample t-test with a degree of freedom of 26). 
Table 4-2 shows the confusion matrix of the model built for macrosteatosis prediction. 
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Table 4-2 : The confusion matrix and metrics for the model built to detect macrosteatosis. 
 
For microsteatosis prediction, the model’s precision, recall and AUROC were 
79.2%, 77%, 78.1%, respectively. The classifier’s accuracy was 78.7%. Table 4-3 shows 
the confusion matrix of the model built for microsteatosis prediction.  
 
Table 4-3 : The confusion matrix and metrics for the model built to detect microsteatosis. 
Actual Predicted  
 Micro Fat Others PRECISION (%) 
Micro Fat 7109 1862 79.24 
Others 2116 7660 78.35 
RECALL (%) 77.06 80.445 
 
 
  Figure 4-3 presents a visual summary of the performance metrics for the different 
steatosis identification models developed using supervised machine learning methods 
described above.  
 
Actual Predicted 
 Central 
Vein 
Macro 
Fat 
Bile 
Duct 
Portal 
Vein 
Portal 
Artery 
PRECISION 
(%) 
Central Vein 230 8 0 25 0 87.45 
Macro Fat 6 343 0 12 0 95.01 
Bile Duct 0 1 17 27 5 30.91 
Portal Vein 15 8 14 298 2 87.9 
Portal Artery 2 4 4 7 13 37.14 
RECALL 
(%) 
90.91 94.23 41.46 79.25 52  
51 
 
 
Figure 4-1 : A scatter plot showing correlation between model-computed percentage steatosis for 
mouse biopsies with respect to the corresponding pathologist grade. 
 
 
Figure 4-2 : Mixed line/bar chart showing the correlation between the computed percentage 
steatosis with the expert pathologist grade. The pathologist grade for mouse samples is shown as 
a bar matching the left axis, and the computed percentage steatosis is shown as a line matching the 
right axis. 
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Figure 4-3 : A graph which represents the different steatosis models generated and their respective 
metrics. 
 
  The expert pathologist validated the classification results on unseen slides for 
detection of steatosis. For macrosteatosis, evaluation by the study expert pathologist of the 
accuracy of predictions made on biopsy samples images unseen previously by the classifier, 
showed 100% accuracy. For microsteatosis, of the one hundred and ten random sub slides 
the detection accuracy was 63%. The pathologist also confirmed that for every unseen slide, 
the classifier had accurately detected microsteatosis on at least one sub slide (i.e., 100% 
sensitivity for detecting any microsteatosis). It is practically impossible for the pathologist 
to label the massive number of macro- or microsteatosis lesions present on an individual 
slide, but the classifier can do that automatically. Here we show examples in Figure 4-4 
(for macrosteatosis) and Figure 4-5 (for microsteatosis), where both the pathologist’s and 
classifier’s labels fell on the same lesion in the hepatocytes but the classifier correctly 
labeled many other lesions in the same area of the biopsy. Figure 4-6 shows an example of 
misclassified microsteatosis.  
  Other histological features of fatty liver such as lobular inflammation or ballooning, 
or artifacts on the slides did not affect the performance of the model for detection of 
macrosteatosis, as evidenced by the 100% accuracy of the classifier. However, they did for 
microsteatosis, where ballooning or artifact was confused by the classifier as microsteatosis 
in some mislabeled cases by the classifier (Figure 4-6). 
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Figure 4-4 : Comparison of annotated macrosteatosis lesions by Pathologist v/s our model.  
The left slide contains annotations given by the pathologist (marked as a point in magenta).  
The right slide contains macro fat lesions detected by the model (marked as point in dark blue). 
 
 
Figure 4-5 : Comparison of annotated microsteatosis lesions by Pathologist v/s our model.  
The left slide contains annotations given by the pathologist (marked as polygons in dark blue).  
The right slide contains micro fat lesions detected by the model (marked as polygons in green). 
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Figure 4-6 : Some misclassified instances of microsteatosis lesions. The left slide contains no 
micro fat according to the pathologist. The right slide contains wrongly classified micro fat lesions 
detected by the model (marked as polygons in green). 
 Lobular and Portal Inflammation 
I. Training Data 
The training data for learning the inflammation model involves the dark regions 
annotated by the expert pathologists, including 163 portal inflammation annotations and 
260 lobular inflammation annotations from 16 liver biopsy images annotated by Dr. C and 
340 portal inflammation annotations and 347 lobular inflammation annotations from 16 
liver biopsy images annotated by Dr. K. 
II. Test Data 
  In order to evaluate the models built to detect both lobular inflammation and portal 
inflammation, 18 unseen slides have been used. The slides are processed and a random set 
of 107 sub-slides are chosen to validate lobular inflammation and 113 sub-slides are chosen 
to validate portal inflammation by the expert pathologists (both Dr C and Dr K). 
III. Detection and quantification results 
  In this study, the supervised machine learning models built to detect macrosteatosis 
and microsteatosis are subjected to 10-fold cross validation. The training data comprised 
of the annotated data given by the expert pathologists. All the present dark regions were 
used by Morusu et al. in their study (5, 6), in this research we have experimented with only 
four of the many dark regions present in the liver biopsy namely, lobular inflammation, 
portal inflammation, normal hepatocyte and bile duct. The results are encouraging, 
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however there can be changes made to the built classifier to reduce the misclassification of 
histological features. 
 Annotations were provided by both the expert pathologists (in total, 503 portal 
inflammation annotations and 607 lobular inflammation annotations). There have been 
many annotation overlaps and therefore, this affects the classifier to some extent. As there 
are only four classes that have been analyzed in this experiment, the relative set of 
annotations being left out is small. For portal inflammation prediction, the model’s 
precision, recall (sensitivity) and area under the curve operator characteristic (AUROC) 
are 86%, 77.1% and 93.2% for portal inflammation and 79.6%, 77.1% and 93.2% for 
lobular inflammation respectively. The overall classifier’s accuracy is 83.6%.  
 
Figure 4-7 : A graph which represents the different inflammation models generated and their 
respective metrics. 
 
  For testing purposes, 18 unseen samples were processed and sent through the 
classifier to detect lobular and portal inflammation respectively. The ratio of each of the 
lobular and portal inflammation areas with the tissue areas is computed and correlation is 
performed with the semi-quantitative grades provided with the expert pathologists. The 
spearman correlation coefficient when lobular and portal inflammation areas are 
compared with Dr. K’s grades are 0.71 and 0.85 and for that of Dr. C’s grades are 0.65 
and 0.62, respectively.  
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Actual Predicted 
 Lobular 
Inflammation 
Normal 
Hepatocyte 
Portal 
Inflammation 
Bile 
Duct 
PRECISION 
(%) 
Lobular 
Inflammation 
4297 3 1206 64 79.6 
Normal 
Hepatocyte 
21 88 0 0 76.5 
Portal 
Inflammation 
914 24 9804 106 86.0 
Bile Duct 165 0 396 552 76.5 
RECALL 
(%) 
79.6 76.5 86.0 76.5 
 
 
 
 
Figure 4-8 : A scatter plot showing correlation between model-computed percentage portal 
inflammation for human biopsies with respect to the corresponding Dr K’s grade. 
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Table 4-4 : The confusion matrix and metrics for the model built to detect inflammation. 
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Figure 4-9 : A scatter plot showing correlation between model-computed percentage lobular 
inflammation for human biopsies with respect to the corresponding Dr K’s grade. 
 
 
Figure 4-10 : A scatter plot showing correlation between model-computed percentage portal 
inflammation for human biopsies with respect to the corresponding Dr C’s grade. 
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Figure 4-11 : A scatter plot showing correlation between model-computed percentage lobular 
inflammation for human biopsies with respect to the corresponding Dr C’s grade. 
 
 
 
Figure 4-12 : A scatter plot showing correlation between model-computed percentage portal 
inflammation for human biopsies with respect to the average of Dr C and Dr K’s pathologist grade. 
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Figure 4-13 : A scatter plot showing correlation between model-computed percentage lobular 
inflammation for human biopsies with respect to the average of Dr C and Dr K’s pathologist grade. 
 
  The expert pathologists validate classification results on unseen slides for detection of 
steatosis. For lobular inflammation, evaluation by Dr K and Dr C have accuracy of 
predictions made on biopsy sample images unseen previously by the classifier as 75%  and  
91%, respectively. On the other hand, for portal inflammation, evaluation by Dr K and Dr 
C have accuracy of predictions made on biopsy samples images unseen previously by the 
classifier as 62.9%  and  84.97%, respectively. Both expert pathologists also confirmed that 
for every unseen slide, the classifier has accurately detected lobular inflammation and portal 
inflammation on at least one sub slide (i.e., 100% sensitivity for detecting any type of 
inflammation). 
  Other histological features of fatty liver such as normal parenchyma or ballooning, or 
artifacts on the slides have affected the performance of the model for detection of any kind 
of inflammation, as evidenced by the validation of unseen samples done by Dr K. 
 Fibrosis 
I. Training Data 
The training data associated to detect fibrosis and its types is based on the blue 
regions annotated by the expert, for this study only Dr K’s annotations have been used. 
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Dr.C’s annotations are present for some types of fibrosis but not all, hence they have not 
been used as part of this study. Dr. K has annotated blue regions, including 186 normal 
fibrosis annotations, 118 portal fibrosis annotations, 128 pericellular annotations, 127 
periportal annotations, 98 bridging annotations and 61 nodule annotations from a set of 18 
liver biopsy images. 
 
II. Test Data 
  The test data to detect the blue regions i.e. the amount of collagen content comprises 
of 18 liver biopsy TC stained slides which are semi-quantitively graded by both the expert 
pathologists. 
 
III. Detection and quantification results 
  In this study, the supervised machine learning models built to detect if a patient is 
affected by abnormal fibrosis and also detect the different types of fibrosis associated are 
subjected to 10-fold cross validation. The training data comprised of the annotated data 
given by the expert pathologists. All the present blue regions could not be used for the 
building of the models which were used to detect fibrosis and its types as it involved a lot 
of overlapped annotations. This is one of the prime reasons for the detection results to be 
comparatively low compared to that of steatosis and inflammation detection. The Figure 
4-14 gives an example of blue region extraction using the method described above in 
Section 3.6.1. 
 
 
Figure 4-14 : An example of blue region detection in a TC Stained sub-slide.   
A) A TC Stained sub-slide. B) Blue regions in the TC Stained sub-slide. 
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  The first experiment conducted involves quantification of the collagen content in 
liver biopsies and correlating the same with the semi-quantitative grades of the experts. 
The amount of collagen content is detected by calculating the blue region areas and 
performing a weighted averages sum of the pixel values in the blue band and thus, taking 
the ratio of the blue region area with the tissue area. The conclusion of this study is that 
even though there can be loads of collagen content in a liver biopsy, it need not necessarily 
imply that the patient is highly affected with fibrosis. For this experiment, a total of 18 
slides were processed and the percentage of collagen in each of them is computed. The 
coefficient of determination of collagen area with Dr. K’s grades is 0.607 and with Dr. C’s 
grades is 0.867. Hence, it is important to categorize the type of fibrosis associated in a liver 
biopsy to determine at what extent a person is affected with NAFLD. 
 
 
Figure 4-15 : A scatter plot showing correlation between model-computed percentage collagen 
content for human biopsies with respect to the Dr K’s pathologist grade. 
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Figure 4-16 : A scatter plot showing correlation between model-computed percentage collagen 
content for human biopsies with respect to the Dr C’s pathologist grade. 
 
 
 
Figure 4-17 : A bar graph which shows semi-quantitative grades given by both Dr. K and  
Dr. C for the given test set of 17 human liver slides. 
 
 
    
y = 310.57x2 - 44.386x + 1.4567
R² = 0.867
-0.5
0
0.5
1
1.5
2
2.5
3
3.5
4
4.5
0 0.05 0.1 0.15 0.2
Fibrosis Collagen content - Correlation with Dr C
-1
0
1
2
3
4
5
1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18
Fibrosis Grade_Dr K Fibrosis Grade_Dr C
63 
 
 Normal 
I. Training Data  
The training data used to detect Normal Fibrosis consists of blue regions 
annotated by expert Dr. K. These regions contain 186 normal fibrosis annotations and 
532 abnormal fibrosis annotations (including the annotations like pericellular, portal, 
periportal, bridging and nodules) from a set of 9 human liver biopsy images. 
 
II. Model Metrics 
In this system, the built machine learning model identifies normal fibrosis 
annotations among the given test data. Table 4-5 represents the confusion matrix which 
gives an insight about the classified results of normal fibrosis and abnormal fibrosis 
annotations. The model predicted 535 annotations as normal and 565 annotations as 
abnormal with the precision of 85.6% and the recall of 83.3%. The Area under Curve 
of Receiver Operating Characteristics (AUROC) is 91.9%. 
 
Table 4-5 : The confusion matrix for the model built to detect Normal Fibrosis. 
Actual Predicted  
  Normal Abnormal 
Normal 458 92 
Abnormal 77 473 
     
 Pericellular 
I. Training Data 
The training set used to detect the pericellular fibrosis annotations comprises of 
the blue regions from a set of 6 human biopsy liver images annotated by the expert Dr. 
K. The expert identified 128 annotations as pericellular and 555 annotations as the other 
types like fibrosis, portal, periportal, bridging and nodules. 
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II. Model Metrics 
In this system, the model predicted 137 annotations as pericellular and 115 
annotations as others from the Test Data. The classified annotations by the model are 
shown in the confusion matrix represented by the table 4-6. The precision of the 
classification model is 76.6% and the recall is 82.7%. 
 
  Table 4-6 : The confusion matrix for the model built to detect Pericellular Fibrosis. 
Actual Predicted  
  Pericellular Others 
Pericellular 105 22 
Others 32 93 
 
 Portal 
I. Training Data 
The training set used to identify the portal fibrosis annotations comprises of 
blue regions classified as 118 portal annotations and 565 other annotations (like 
normal, pericellular, periportal, bridging and nodules) from a set of 6 human liver 
biopsy images by the expert Dr. K. 
 
II. Model Metrics 
The model classified the test data as 365 portal annotations and 293 other 
annotations with a precision of 77% and a recall of 84.4%. The comparison between 
the actual and predicted annotation results is shown in the confusion matrix 
represented by the table 4-7.  
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Table 4-7 : The confusion matrix for the model built to detect Portal Fibrosis.  
Actual Predicted  
  Portal Others 
Portal 281 52 
Others 84 241 
 
 Periportal 
I. Training Data 
The training set contains the blue regions annotated as periportal fibrosis 
and other fibrosis annotations (like normal, pericellular, portal, bridging and 
nodules) by the expert Dr. K. The expert Dr. K identified 127 periportal fibrosis 
annotations and 556 other annotations from 6 different human liver biopsy images. 
 
II. Model Metrics 
The table 4-8 portrays the confusion matrix with the actual and predicted 
periportal and other annotations. The model correctly identified 129 periportal 
annotations and 117 other annotations with the precision and recall of 72.1% and 
76.9% respectively. 
 
Table 4-8 : The confusion matrix for the model built to detect Periportal Fibrosis. 
Actual Predicted  
  Periportal Others 
Periportal 93 28 
Others 36 89 
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 Bridging 
I. Training Data 
The training set used to identify bridging fibrosis annotations is selected 
across 9 human liver biopsy images by the expert Dr. K. The annotations contain 
98 bridging fibrosis and 620 other fibrosis (like normal, pericellular, portal, 
periportal and nodules). 
 
II. Model Metrics 
The classification results are interpreted as a confusion matrix shown in the 
table 4-9. The model predicted 2159 bridging fibrosis annotations with a precision 
of 84.9% and a recall of 91.7%. 
 
  Table 4-9 : The confusion matrix for the model built to detect Bridging Fibrosis. 
Actual Predicted  
  Bridging Others 
Bridging 1833 167 
Others 326 1674 
 
 Nodule 
III. Training Data 
The training set used to predict the nodule fibrosis annotations is selected 
from a set of 9 human liver biopsy images. The expert Dr. K annotated the input 
images into a total of 61 nodules and 657 other fibrosis annotations (including 
normal, pericellular, portal, periportal and bridging annotations). 
 
IV. Model Metrics 
The model predicted 2040 annotations as nodules and 1960 annotations. 
The precision of the learning model is 89.8% and the recall is 91.6%. The confusion 
matrix with correct and incorrect classification is presented in the table 4-10. 
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Table 4-10 : The confusion matrix for the model built to detect Nodule Fibrosis. 
Actual Predicted  
  Nodules Others 
Nodules 1831 169 
Others 209 1791 
 
  For the detection of normal fibrosis in liver biopsies, a model is built with two 
classes – normal fibrosis and abnormal fibrosis which comprises of a random subset of all 
the different kinds of fibrosis respectively. The model thus built contains a total of 528 
features which comprise of different set of morphological features, scaled representation 
features and Gabor features (as discussed previously). Because of the irregularity of the 
annotations, random subsampling takes place to fill the abnormal fibrosis class to avoid 
overfitting of the model (886 normal fibrosis and 990 abnormal fibrosis). Feature extraction 
is done using information gain such that the top 200 attributes are chosen to build the model. 
There are two models built for the normal fibrosis detection, one with all the attributes and 
the other with top 200 attributes. The best results obtained were with the former which 
recorded a precision, recall and area under ROC (AUROC) characteristic curve of 85%, 
79.5% and 90.5% respectively. 
  In order to detect the different other types of fibrosis, morphological features, 
scaled representation features and Gabor features are computed for the annotated areas by 
Dr K and individual models are built for all the five types of fibrosis. The models thus built 
using the above methods described detect portal fibrosis, periportal fibrosis and pericellular 
fibrosis with a precision of 77%, 72.1% and 76.6% respectively. However the model did 
not give significant results for the detection of bridging fibrosis and cirrhosis.  
 The next two experimental models built involve detection of bridging fibrosis and 
cirrhosis. Cirrhosis involves detection of nodules in a liver biopsy. These are oval shaped 
hollow blue regions of different sizes. Therefore, detection of SURF features at different 
scales will determine them to be unique as at the highest possible scale, the elliptical shape 
hollow nodule collapses to a point. In the case of bridging fibrosis, there can be other types 
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of fibrosis within them. Hence, to capture the stream of blue regions across the tissue areas, 
HOG descriptors are useful. Therefore, to detect the above two mentioned types of fibrosis, 
texture features, HOG descriptors and SURF features across different scales are computed 
and  two class models involving nodules and others (a random subsampling of the other set 
of fibrosis types) as well as bridging fibrosis and others is built. There are a total number 
of 305 features that are computed which uniquely determine a blue region. The model 
results for detection of bridging fibrosis and nodules have a precision of 84.9% and 89.8%, 
respectively. 
 There are a lot of overlaps present in the given annotations for each type of fibrosis. 
The use of square annotations to annotate this kind of fibrosis is something which needs to 
be re-evaluated in the future. Some scope of improvements can be done if the annotations 
are provided in a little more accurate way, thereby reducing the conflict of two different 
types of fibrosis in the same region. 
 
Table 4-11 : The different types of fibrosis detection with their respective precisions. 
FIBROSIS TYPE PRECISION 
Normal 85.6% 
Pericellular 76.6% 
Portal 77% 
Periportal 72.1% 
 
Bridging 84.9% 
Cirrhosis 89.8% 
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5. DISCUSSION 
  The results presented above indicate that it is feasible to construct a decision support 
system for pathologists who diagnose NAFLD using a supervised machine learning approach. The 
use of such a system would minimize the variability and subjectivity present in the current semi-
quantitative grading system. 
  Pathologists can have a difference of opinion while scoring a liver biopsy slide for NAFLD, 
which is one of the main motivations to the research presented in this thesis. The pathologists 
involved in this study are well respected and experts in their field, however, the manual semi-
quantitative grading system is prone to subjectivity and variability. This has been indicated in our 
study. The correlation with the pathologist grade is an important statistic, but it is also important 
to consider the overall accuracy of the various classifiers built. The correlation with pathologist 
grade is significant based on the underlying assumption that the pathologist is 100% correct. Over 
a period of time, there is a possibility of considering this type of continuous assessment for the 
detection of NAFLD thereby, eliminating the use of pathologist semi-quantitative grades. 
  The classifiers built to detect different types of fibrosis can have better accuracies, ideally. 
There are a few points which could enhance the above set of models. Firstly, the annotations used 
to build fibrosis classifiers contain many overlaps. This can be improved by the introduction of 
new set of markers for each type of fibrosis. Secondly, the pathologists' disagreement on semi-
quantitative grades indicate that the correlation analysis performed on each their scores yield better 
results as compared to pathologist to pathologist correlation. The inclusion of many number of 
pathologists could help building widely accepted classifiers and eliminate variability. Thirdly, the 
use of random subset of slides for validation can be subject to unevenness i.e. there is a possibility 
that some of the randomly chosen sub-slides can in fact belong to the negative class. 
  Finally, performance of this type of system is very important while introducing it in a 
clinical setting. The current execution time is not very efficient, as tools like MATLAB, WEKA 
used to develop these classifiers are very good for prototyping. The use of a programming language 
which could efficiently utilize system resources could make this process faster compared to the 
current system. 
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6. CONCLUSION 
  The above section elaborates on the promising results for determining various histological 
features in liver biopsies (both mice and human) which can help detect NAFLD. The use of various 
image processing techniques involved to generate unique set of features which are then used to 
build supervised machine learning models is therefore, a unique and more accurate measure of 
detecting different anatomical and histological features in biopsies as there can be enumerable 
number of slides and it becomes tough for a pathologist to not miss any of them. Hence, it also 
reduces the inter-observer and intra-observer error associated while performing the semi-
quantitative assessment by the pathologists. 
  For all our experimental studies conducted, we receive the annotations and the semi-
quantitative grades from the expert pathologists who are considered the “gold standard” in the field 
of histopathology. Despite the fact the pathologists are one of the best in their areas, there is a 
definite disagreement between them while grading slides. This clearly accounts to our process of 
quantification and detection of different histological set of features, which would be very 
beneficial for the doctors in the field of Hepatology and Pathology. This tool has been built to 
serve as a utility to the doctors and not to replace their existence. 
  The improvements done to the models which determine the steatosis area in a liver biopsy 
clearly indicate that this tool is “ready for use” in clinical trials for detecting macrosteatosis and 
microsteatosis as mentioned by Morusu et al. in their study (5, 6). Apart from this, the encouraging 
results for detection of both the types of inflammation indicate that with more improvements put 
in place, this tool can be used soon by doctors in their clinical trials. In this study, the addition of 
detecting collagen in liver biopsies and also categorizing the different types of fibrosis in a liver 
biopsy is a step in the right direction to build a fully automated tool to detect NAFLD in mice and 
humans.  
  The current constraint for this tool however lies in the fact that, it takes time to evaluate 
the above mentioned histological features. Having said that, improvements have been made to 
make it a speedy robust system and running the same using various big data technologies should 
be a boost as we move forward. 
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